Pharmacology: Pharmacokinetics: After absorption or IV administration, 80% of a single neostigmine dose is excreted by the kidney in the unchanged (50%) and metabolized (30%) forms in 24 hours. The elimination half-life is approximately 51 to 91 minutes. Protein binding in human serum albumin is reported to range from 15 to 25%.